Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.
Through the agreement, Mayo Clinic will use the Endoluxe Visualization System, a tool that utilizes AI to provide clinicians with data during surgical procedures, and in turn Endoluxe will use the insights gained to advance development of its platform, according to a Dec. 5 Endoluxe news release.
Endoluxe designs its video platforms to be vendor agnostic.